Cullen/Frost Bankers vs Huntington Bancshares
CFR and HBAN side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CFR and HBAN compare
Huntington Bancshares is the larger company, worth 3.3 times as much as Cullen/Frost Bankers ($31.9B against $9.8B).
On earnings, Huntington Bancshares is cheaper: it trades at 12.2× trailing earnings, against 14.6× for Cullen/Frost Bankers.
Huntington Bancshares grew revenue faster over the last twelve months (20.5% versus 6.6% for Cullen/Frost Bankers).
Huntington Bancshares keeps more of each dollar of sales as profit, with a net margin of 133% compared with 29.5% at Cullen/Frost Bankers.
Both pay dividends: Cullen/Frost Bankers yields 2.6% and Huntington Bancshares 3.9%.
Huntington Bancshares scores higher on the StockData Score (15 against 10 for Cullen/Frost Bankers), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CFR | HBAN |
|---|---|---|
| Size and price | ||
| Market cap | $9.8B | $31.9B |
| Share price | $157.60 | $15.78 |
| Change, 1 year | 29.8% | 4.1% |
| Change, 5 years | 16.7% | −0.44% |
| Beta (5Y) | 0.69 | 1.00 |
| Employees | 6,008 | 12K |
| StockData Score | ||
| Total score | 10 | 15 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 0 | 1 (better) |
| Performance score | 3 (better) | 2 |
| Health score | 3 | 5 (better) |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 14.6× | 12.2× (better) |
| P/S | 4.2× (better) | 17.6× |
| P/B | 2.5× | 1.0× (better) |
| P/FCF | 16.9× | 11.9× (better) |
| PEG | 3.62 | – |
| FCF yield | 5.9% | 8.4% (better) |
| Fair value | $123.68 | $17.36 |
| Margin of safety | −27.4% | 9.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 6.6% | 20.5% (better) |
| Revenue growth, 5Y average | 9.2% | 12.1% (better) |
| Net income growth (TTM) | 8.2% | 13.6% (better) |
| EPS growth (TTM) | 10.7% (better) | −4.4% |
| EPS growth, 5Y average | 14.2% | 15.0% (better) |
| Profitability | ||
| Net margin | 29.5% | 133% (better) |
| FCF margin | 24.8% | 148% (better) |
| Return on equity | 16.3% (better) | 9.0% |
| Financial health | ||
| Debt / equity | – | 0.10 |
| Altman Z-score | 0.28 (better) | 0.12 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 2.6% | 3.9% (better) |
| Payout ratio | 37.4% | 42.5% |
| Years of dividend growth | 16 (better) | 0 |
| Dividend growth, 5Y average | 6.7% (better) | 0.66% |
| Buyback yield | 2.7% | – |
| Shareholder yield | 5.3% (better) | 3.9% |
| Ownership | ||
| Held by institutions | 96.3% | 86.9% |
| Held by insiders | 1.3% | 0.91% |
| Insider net buying, 12 months | −$350K (better) | −$6.3M |
| Short interest, % of float | 7.2% | – |
Go deeper
- CFR stock overview
- CFR income statement
- CFR valuation and score
- HBAN stock overview
- HBAN income statement
- HBAN valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.